Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2024年6月25日
	新闻
	Imdelltra for Small Cell Lung Cancer Addresses Key Unmet Needs - Cure Today Cure Today Imdelltra has offered a new treatment option for patients with small cell lung cancer that "is not like anything we've ever seen before," an ... 标记为不相关
	UK Stocks: AstraZeneca's (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial Markets Insider - Business Insider In top news on UK stocks, AstraZeneca PLC (GB:AZN) released disappointing results for its cancer drug, Imfinzi, in an advanced lung cancer tria... 标记为不相关
	Durvalumab Misses Primary End Point in Early-Stage NSCLC - Targeted Oncology Targeted Oncology [Durvalumab] has helped change the treatment landscape and achieved multiple positive phase 3 trials for patients with earlier stages of lung cancer. 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈